Manjool Shah, MD, clinical associate professor of ophthalmology and visual sciences for the Kellogg Eye Center, discussed how ...

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...

In India, we are quick to visit a doctor for fever, stomach pain, or a bad cough. But when it comes to the eyes, most people ...

Glymphatic dysfunction in IIH appears to be an adaptive response to elevated pressure rather than a primary cause of the ...

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

Background Intraocular pressure (IOP) exhibits significant fluctuations in response to changes in body posture. Postural modification may serve as a potential adjunctive strategy for IOP management in ...

SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...

Accomplished global commercial leader with deep expertise in retina drug launchesPrimary architect for the industry-defining launch of EYLEA® ...

A renewed focus on glaucoma comes with each new year, as January is Glaucoma Awareness Month.Glaucoma has been estimated to ...

To yield the benefits of interventional glaucoma treatment, ophthalmologists need a roadmap for how to implement it, according to a speaker here. At the Hawaiian Eye 2026 meeting, Christine Funke, MD, ...

Tirzepatide glaucoma risk was lower than with selective glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus ...